A European Consensus on the Consistent Use of the Term "Keratinocyte Cancer"

Area of Science:

• Dermatology
• Oncology
• Medical Terminology

Background:

• Keratinocyte-derived skin cancers, including basal cell carcinoma and squamous cell carcinoma, are often grouped as non-melanoma skin cancer.
• The term "non-melanoma skin cancer" is considered imprecise and potentially misleading.
• There is a need for more accurate terminology to reflect the clinical and scientific significance of these keratinocyte-derived neoplasms.

Purpose of the Study:

• To propose and advocate for the adoption of the term "keratinocyte cancer" to replace "non-melanoma skin cancer".
• To enhance the precision of terminology used in clinical practice and scientific literature for keratinocyte-derived skin cancers.

Main Methods:

• A consensus approach was initiated by experienced dermato-oncologists.
• A vote was conducted among consensus group members and international delegates regarding the proposed terminology change.

Main Results:

• Unanimous agreement was reached among consensus group members to consistently use "keratinocyte cancer".
• International delegates also voted in favor of the revised terminology.

Conclusions:

• The term "keratinocyte cancer" is more precise and etiopathogenically correct for malignancies originating from keratinocytes.
• Consistent use of "keratinocyte cancer" is expected to improve patient-physician communication and better represent these common skin cancers.